Integrin α3 (ITGA3) gene mutations are associated with Interstitial Lung disease, Nephrotic syndrome and Epidermolysis bullosa (ILNEB syndrome). To date only six patients are reported: all carried homozygous ITGA3 mutations and presented a dramatically severe phenotype leading to death before age 2 years, from multi-organ failure due to interstitial lung disease and congenital nephrotic syndrome. The involvement of skin and cutaneous adnexa was variable with sparse hair and nail dysplasia combined or not to skin lesions ranging from skin fragility to epidermolysis bullosa-like blistering.

Viable phenotype of ILNEB syndrome without nephrotic impairment in siblings heterozygous for unreported integrin alpha3 mutations / Colombo, E.A., Spaccini, L., Volpi, L., Negri, G., Cittaro, D., Lazarevic, D., Zirpoli, S., Farolfi, A., Gervasini, C., Cubellis, M.V., Larizza, L.. - In: ORPHANET JOURNAL OF RARE DISEASES. - ISSN 1750-1172. - 11:1(2016), p. 136. [10.1186/s13023-016-0514-z]

Viable phenotype of ILNEB syndrome without nephrotic impairment in siblings heterozygous for unreported integrin alpha3 mutations

CUBELLIS, MARIA VITTORIA;
2016

Abstract

Integrin α3 (ITGA3) gene mutations are associated with Interstitial Lung disease, Nephrotic syndrome and Epidermolysis bullosa (ILNEB syndrome). To date only six patients are reported: all carried homozygous ITGA3 mutations and presented a dramatically severe phenotype leading to death before age 2 years, from multi-organ failure due to interstitial lung disease and congenital nephrotic syndrome. The involvement of skin and cutaneous adnexa was variable with sparse hair and nail dysplasia combined or not to skin lesions ranging from skin fragility to epidermolysis bullosa-like blistering.
2016
Viable phenotype of ILNEB syndrome without nephrotic impairment in siblings heterozygous for unreported integrin alpha3 mutations / Colombo, E.A., Spaccini, L., Volpi, L., Negri, G., Cittaro, D., Lazarevic, D., Zirpoli, S., Farolfi, A., Gervasini, C., Cubellis, M.V., Larizza, L.. - In: ORPHANET JOURNAL OF RARE DISEASES. - ISSN 1750-1172. - 11:1(2016), p. 136. [10.1186/s13023-016-0514-z]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/667489
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 23
social impact